LEO-27847

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameLEO-27847
Drug Alias NameLEO-27847
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHyperparathyroidism, SecondaryRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaPolandGermany +[4] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma Inc
Active IndicationsN/A
Inactive IndicationsHyperparathyroidism, SecondaryRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A